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T a b l e  1. Dermatoses characterized by pustulation revealed a leucocytosis of 14 x 10 /1 with 98% neutrophils
and an erythrocyte sedimentation rate of 3 mm/h. Blood
cultures were negative; however, culture of a
revealed a mild growth of group G Streptococci and
Staphylococcus aureus, considered unlikely nevertheless to
have a causal role in his generalized skin eruption.
Histopathological examination of a 4-mm punch
sy from the skin of the thigh revealed a partly
spongiotic epidermis with some intraepidermal pustules
containing both eosinophils and neutrophils (Fig. 2); no
argement of the rete ridges was 
was admitted in very ill condition to our in-patient observed. The papillary dermis was oedematous and a
Sneddon- Wilkinson subcorneal pustular dermatosis 
Acute pustular psoriasis (von Zumbusch type) 
Pustulosis palmaris et plantaris (Andrews type) 
Acute generalized pustular bacteride 
Subcorneal pustules of erythema niultiforme 
Subcorneal pustules of Sweet’s syndrome 
impetigo herpetiformis
or
department with a fever of 3(>5"C. inflammatory infiltrate of mainly
Over the face, neck, trunk and upper extremities there histiocytes and eosinophils around dermal blood vessels
was a sharply demarcated ery thema with numerous non- was seen, with some perivascular neutrophils and dia- 
follicular, partly confluent, pinhead-sized pustules (Fig. 1). ;sis of re was pre
On the lower extremities the same picture was complicated scribed at a dosage of 40 mg/day for 4 days; the eruption
by peteehiae. Ill-defined erythema with crusts and pustu- subsided within 1 week without scarring. Six months 
lation was
aspects of the fingers. The nails and mucous membranes
were normal. No enlargement of tonsils or pharyngeal cutaneous
lymph nodes was observed. Laboratory examination test was negative, but intracutaneous testing with 0-2 ml
x\ on the palms and volar and interdigital after the cutaneous reaction to clemastine, no relapse had
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T a b l e  2. Drugs which may induce toxic 
pustuloderma
Ci 1 0 %  Blackwell  Sc ien ee  I,tel, Clinical ¡nul Expérimenta! Dcninilti/nuy, 21,  29.5 295
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of clemast ine (1 mg/ml) in the right ventral forearm with a !-• Bean SI'. Acneiform eruption from tetracycline. Hr J  Dermatol
control of 0*2 ml saline in the left forearm produced a weal 
and Hare reaction with a weal diameter of 28-0 mm at 10 
inin persisting for more than 24 h; no pustules developed. 
Seven healthy control subjects were tested similarly, weal 
size being less in them at 10-5 to 16-0 mm (mean 13*6 
mm); however, the specificity of the positive provocation 
test in our patient is clearly not absolutely certain.
1^71; 85: 585 6.
13. Rouehouse B. Acute generalized exanthematous pustular derma­
titis and viral infection. Dermatologien 1986; 173: 180..4.
14. Wintroub BU, Stern RS, Arndt KA. Cutaneous reactions to 
drugs. In: Fitzpatrick TB, Eisen AZ, Wolff K  et til., eds. 
Dermatology in General Medicine, Vol. 2, 3rd edn. New York:
McGraw-Hill, 1987: 1353 66,
15. Grattan CEIL Generalized eruptive pustular drug’ rash due to 
naproxen. Dermatologien 1989, 179: 57 8.
16. Diaz LA, Provost I T ,  Tomasi TB. Pustular necrotizing' angiitis. 
Arch Dermatol 1973; 108: 114 18.
17. Voss M. Eine Prednison Allergie mit pustulösem Exanthem. 
Dermatol Monatsscii 1988; 174: 221 5.
18. Ärmster I I, Schwarz T. Arzneimittelreaktion auf Amoxicillin unter 
dem Bild eines toxischen Pustuloderms. Hautarzt 1991; 42: 713 16.
19. Ogino A, Tagami I I, Takahashi C, Higuchi '1’. Generalized pustular 
toxic erythema: pathogenetic relationship between pustule and 
epidermal appendage. Acta Derm Venereal 1978; 58: 257 61.
disorder with malaise and fever; (iii) the presence of 20. Ogoshi M, Yamada Y, Tani M. Acute generalized exanthematic
pustulosis induced by cefaclor and aectazolamide. Dermatologien
Various dermatoses are characterized by 
("Fable 1). Within the spectrum of such dermatoses, 
toxic pustuloderma has unique characteristics: (i) the 
time relat ionship bet ween administrat ion of the drug and 
the appearance of the eruption;8 (ii) the acute onset of the
spongiform superficial pustules, papillary oedema and a 
polymorphous perivascular infiltrate with numerous 
eosinophils, also present in the epidermis; (iv) signs of
(v) the absence of comedones;12 and (vi) 
negative bacterial and viral cultures .L'
Recently a variety of drugs have been reported to 
cause generalized pustular drug rashes (Table 2), and the 
variability of the drug classes which may cause the 
condition suggests that a common pathway is likely to
n
1992; 184: 142 4.
21, Jackson II, Vion B, Levy PM. Generalized eruptive pustular 
drug rash due to cephalexin. Dermatologica 1988; 177: 292 4. 
Stough D, Guin JD ,  linker O F ,  Haynie L. Pustular eruptions 
following administration ofccfazolin: a possible interaction with
methyldopa . J  A m  Acad Dermatol 1987; 16: 1051 2,
Kalb RE, Grossman ME. Pustular eruption following adminis­
tration of cephradine. Cutis 1986; 38: 58—60.
24. MacDonald K JS. Pustular dermatosis induced bv cotrimoxazole.' 
B r J  Dermatol 1986; 293: 1279 80.
»
be for this reaction pattern. The patient 25. Escallier F, Dalac S, Foucher J L  et al. Pustulose exanthema tique
• .* f ■* * ß V  I M «  ^ ^ 1 4 «  ♦ ♦ V i f  f  1 I 4 v  k
described in this report developed the disorder following 
clemastine therapy. Although we have not been able to 
prove a definite causal association, we feel that it is likely
aiguë généralisée. Imputabilité à l’imipinème (Tiénam). Ann  
Dermal al Vénereol 1989; I l  6: 407 9.
26. Braun-Falco O, Luderschmidt C, Maeiejcwski W, Scherer R. 
Pustulosis acuta generalisata. Hautarzt 1978; 29: 371 7.
that the drug precipitated the condition. The pathogen- 27. Bernard P, Amici JM , Catanzano G et al. Toxidermie pustuleuse
esis might be either a drug-specific immune response, or 
else a non-immunological process.14
aiguë généralisée. A propos d 'un  cas induit par la josamycine. 
Ann Dermatol Vene reo I 1989; 116: 31 3.
28. Röckl II. Mcdikamcntenallergische Vasculitis leueoeytodastica
Exanthems.unter dem Bild eines generalisierten
Ilaulurzt  1981; 32: 467 70.
29. Shelley ED, Shelly WB. T h e  subcorneal pustular drug eruption: 
an example by norfloxacin. Cutis 1986; 38: 58 60.
30. Commens CA, Fischer GO. Toxic pustuloderma following 
carbamazepinc therapy. Arch Dermatol 1988; 124: 178 9,
II. Toxic pustuloderma: a new entity. .7 R Soc Med  1984; 77 31. Gebaucr K, Molgate C, Navanttnam A. Toxic pustuloderma.
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